Table 2—

Patient characteristics by treatment group

Usual titration and laboratory A1CUsual titration and POC A1CActive titration and laboratory A1CActive titration and POC A1CTotal
n1,4911,3631,5011,3665,721*
Age (years)57 ± 1157 ± 1257 ± 1257 ± 1157 ± 12
Sex, male/female (%)52/4853/4749/5150/5051/49
Race
    White1,057 (71)968 (71)1,026 (68)983 (72)4,034 (71)
    Black237 (16)201 (15)269 (18)207 (15)914 (16)
    Hispanic149 (10)146 (11)154 (10)138 (10)587 (10)
    Other45 (3)41 (3)51 (4)35 (3)172 (3)
Duration of diabetes (years)8.4 ± 6.48.4 ± 6.48.6 ± 6.48.7 ± 6.48.5 ± 6.4
BMI (kg/m2)34.5 ± 7.434.3 ± 7.434.2 ± 7.634.4 ± 7.534.3 ± 7.5
A1C (%)8.9 ± 1.58.9 ± 1.68.9 ± 1.68.8 ± 1.58.9 ± 1.5
Fasting SMBG (mg/dl)209 ± 69212 ± 71212 ± 73209 ± 68211 ± 70
Prior therapy (%)
    Sulfonylurea alone1312141213
    Metformin alone98888
    TZD alone11111
    Sulfonylurea + metformin3940404140
    Sulfonylurea + TZD45534
    Metformin + TZD44333
    Sulfonylurea + metformin + TZD1819171818
  • Data are means ± SD, n (%), or n unless otherwise noted.

  • * N varies based on availability of data.